Literature DB >> 18028188

EFNS guideline on diagnosis and management of limb girdle muscular dystrophies.

F Norwood1, M de Visser, B Eymard, H Lochmüller, K Bushby.   

Abstract

The limb girdle muscular dystrophies (LGMD) are termed as such as they share the characteristic feature of muscle weakness predominantly affecting the shoulder and pelvic girdles; their classification has been completely revised in recent years because of elucidation of many of the underlying genetic and protein alterations in the various subtypes. An array of diagnostic measures is possible but with varying ease of use and availability. Several aspects of muscle cell function appear to be involved in the causation of muscle pathology. These cellular variations may confer some specific clinical features thus permitting recognition of the LGMD subtype and hence directing appropriate levels of monitoring and intervention. Despite an extensive literature on the individual limb girdle dystrophies, these publications may be impenetrable for the general neurologist in this increasingly complex field. The proposed guidelines suggest an approach to the diagnosis and monitoring of the limb girdle dystrophies in a manner accessible to general neurologists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18028188     DOI: 10.1111/j.1468-1331.2007.01979.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  23 in total

1.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.

Authors:  Cristina Dias; Murat Sincan; Praveen F Cherukuri; Rosemarie Rupps; Yan Huang; Hannah Briemberg; Kathryn Selby; James C Mullikin; Thomas C Markello; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

Review 2.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

3.  Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.

Authors:  DeWayne Townsend; Soichiro Yasuda; Elizabeth McNally; Joseph M Metzger
Journal:  FASEB J       Date:  2011-06-10       Impact factor: 5.191

4.  Adenosine A(3) receptor stimulation induces protection of skeletal muscle from eccentric exercise-mediated injury.

Authors:  Ruibo Wang; Maria L Urso; Edward J Zambraski; Erik P Rader; Kevin P Campbell; Bruce T Liang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-28       Impact factor: 3.619

Review 5.  Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.

Authors:  David Verhaert; Kathryn Richards; Jill A Rafael-Fortney; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2011-01       Impact factor: 7.792

6.  Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.

Authors:  Véronique Bolduc; Gareth Marlow; Kym M Boycott; Khalil Saleki; Hiroshi Inoue; Johan Kroon; Mitsuo Itakura; Yves Robitaille; Lucie Parent; Frank Baas; Kuniko Mizuta; Nobuyuki Kamata; Isabelle Richard; Wim H J P Linssen; Ibrahim Mahjneh; Marianne de Visser; Rumaisa Bashir; Bernard Brais
Journal:  Am J Hum Genet       Date:  2010-01-21       Impact factor: 11.025

Review 7.  Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature.

Authors:  Adam Ogna; Maria-Antonia Quera Salva; Helene Prigent; Ghassane Mroue; Isabelle Vaugier; Djillali Annane; Frederic Lofaso; David Orlikowski
Journal:  Sleep Breath       Date:  2015-09-04       Impact factor: 2.816

8.  Atypical manifestation of late onset limb girdle muscular dystrophy presenting with recurrent falling and shoulder dysfunction: a case report.

Authors:  Markus Dietmar Schofer; Thilo Patzer; Markus Quante
Journal:  Cases J       Date:  2008-12-16

9.  Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.

Authors:  Fiona L M Norwood; Chris Harling; Patrick F Chinnery; Michelle Eagle; Kate Bushby; Volker Straub
Journal:  Brain       Date:  2009-09-18       Impact factor: 13.501

10.  Assessment of Nocturnal Hypoventilation by Different Methods and Definitions in Children with Neuromuscular Disease: Oxycapnography and Blood Gas Analysis.

Authors:  Yetkin Ayhan; Elif Yuksel Karatoprak; Zeynep Reyhan Onay; Sinem Can Oksay; Saniye Girit
Journal:  Medeni Med J       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.